Skip to content
WeighLab
Provider review

GOAL.MD Review: Price, Pros & Cons

By The WeighLab Bench, Tools & Data Desk

GOAL.MD is a physician-run telehealth weight-loss practice, led by Chief Physician Dr. Michael Mimlitz, MD.

In this review

Compounded drugs are not FDA-approved. Treatment requires a clinician's assessment. Understand compounded GLP-1 treatment.

Check GOAL.MD prices Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.

Prices at a glance

Semaglutide
$179/moMonth-to-month (same at every dose, no auto-billing; $99/mo on a 12-month plan paid up front, compounded)
Tirzepatide
$249/moMonth-to-month (same at every dose, no auto-billing; $159/mo on a 12-month plan paid up front, compounded)
Coverage
All 50 states
Brand-name
Yes

Semaglutide · estimated annual cost

$2,148

Tirzepatide · estimated annual cost

$2,988

Who GOAL.MD may suit

Shoppers who want a named physician-led practice with one flat compounded price at every dose and no auto-billing.

Where the value is

  • Named Chief Physician (Dr. Michael Mimlitz, MD) rather than an anonymous provider network
  • One flat price at every dose and no auto-billing: you reorder when you are ready
  • Brand Ozempic, Wegovy and Zepbound are available through a $95 prescription-forwarding service, plus a semaglutide micro-dose program from $197/mo
  • Displays LegitScript and BBB verification badges

The tradeoffs

  • The $99 and $159 'from' prices need a 12-month plan paid up front ($1,188 and $1,908); month to month is $179 and $249
  • No named compounding pharmacy — only generic '503A & 503B licensed U.S. pharmacies' language
  • Brand-name medication is paid for separately through LillyDirect, NovoCare or TrumpRx, on top of the $95 forwarding fee

How GOAL.MD prices compounded GLP-1s

GOAL.MD sells compounded semaglutide and tirzepatide injections at one price for every dose. What changes the price is how much you pay up front. Each drug has four options: month to month, or a three-, six- or twelve-month plan charged once, in full, at the start. The longer the plan, the lower the monthly rate, and the twelve-month plan is the figure GOAL.MD's ads lead with. Tirzepatide costs more than semaglutide at every plan length.

The price covers the physician evaluation and ongoing supervision, the medication from a licensed U.S. pharmacy, unlimited nutrition coaching and free expedited shipping. GOAL.MD is cash pay only. It doesn't bill insurance, but it accepts HSA and FSA cards and offers Affirm, Afterpay and Klarna. Confirm the current monthly figure for your drug and plan before you pay, because the advertised rate assumes a year paid in advance.

Considering GOAL.MD?

Check the plan total, billing period and cancellation terms before you enroll. A clinician decides whether treatment is appropriate.

No automatic refills on compounded plans

This is the part of GOAL.MD that stands out. It doesn't auto-bill its compounded programs. Your first payment covers the consultation, the physician's evaluation and the first shipment. Around day 21, before your supply runs out, the care team contacts you. If you want to continue, they process the next order; if you want to pause or stop, nothing is charged and no cancellation notice is needed.

The flip side is that every compounded order is final once it's paid. Because the medication is made for you, GOAL.MD won't cancel or refund it after payment, and that includes a prepaid plan.

The brand-name option

GOAL.MD's physicians can also prescribe Wegovy, Ozempic and Zepbound through its Brand-Name GLP-1 Access program. You pay GOAL.MD $95 a month for physician supervision, or $255 for three months, $450 for six or $780 for twelve. The medication itself is bought separately through the drugmakers' own programs, LillyDirect and NovoCare, so your total is the drug plus the fee.

GOAL.MD's pages describe this fee two ways. One says it's billed automatically while you stay enrolled and can be canceled before your next refill is authorized. Another says it's a one-time payment with no stored card. Ask which applies before you sign up. Either way, once a physician has started clinical work for a period, the fee isn't refunded or prorated.

Who's behind it

GOAL.MD is a veteran-owned telehealth practice founded in 2019. It names its physicians, led by Chief Physician and co-founder Dr. Michael Mimlitz, MD, with Dr. Michael Fitch and Dr. Joel Jones. The intake takes about three minutes and a licensed physician decides whether to prescribe. GOAL.MD says it serves all 50 states, though which drug you can get depends on your state and pharmacy eligibility.

You can reach a person by phone, weekdays 9 a.m. to 5 p.m. Central. GOAL.MD doesn't name the 503A or 503B pharmacies that compound its medication, so ask who will fill yours. Compounded semaglutide and tirzepatide are not FDA-approved.

The Index scorecard

GOAL.MD scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month66/100
Price Transparency94/100
Nationwide Access86/100
Formulation Options79/100
Clinical Oversight70/100
Contract Flexibility47/100

The bottom line

GOAL.MD is a physician-run telehealth weight-loss practice, led by Chief Physician Dr. Michael Mimlitz, MD.

Compare the total cost of other GLP-1 programs and alternatives to GOAL.MD before deciding. A clinician should help you choose the right treatment.

Other programs to compare with GOAL.MD

These are partners: we may earn a commission if you sign up, at no cost to you.

  • Peter MDPartner

    Semaglutide modeled $149/mo · Tirzepatide modeled $249/mo

    One account across six verticals — TRT, ED, weight loss, GLP-1, men's hair loss and NAD+ — from a physician-prescribed telehealth brand running since 2021, at a renewal price ($249/mo tirzepatide) well above its own $149 first-month headline.

  • WellorithmPartner

    brand-name Semaglutide modeled $899/mo · brand-name Tirzepatide modeled $1,199/mo

    Wellorithm sells brand Wegovy at $899 a month and Zepbound or Ozempic at $1,199, with compounded semaglutide and dissolving tablets offered but not priced until you start the quiz.

  • Gala HealthPartner

    Tirzepatide modeled $179/mo

    Every dose at one published price, with the whole price list visible before you hand over an email — but the only terms it sells on are a yearly subscription at $179 or a three-month plan at $199, so there is no monthly number here to compare with anyone else's.

Compare with other providers

The providers whose Cost-Efficiency Index scores sit closest to GOAL.MD's. See the alternatives to GOAL.MD.

Explore more provider reviews

Pricing, states and verification reflect GOAL.MD's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on GOAL.MD's site. Not medical advice; see our disclosure.

← Back to the value leaderboard